Featured Research

from universities, journals, and other organizations

Treat the fungus among us with nontoxic medicinal compound

Date:

September 12, 2013

Source:

Kansas State University

Summary:

A research team has found a breakthrough herbal medicine treatment for a common human fungal pathogen that lives in almost 80 percent of people. The team discovered a medicinal herb called Gymnema slyvestre is both nontoxic and blocks the virulence properties of a common fungus called Candida albicans.

Related Articles

Govindsamy Vediyappan, assistant professor of biology, noticed that diabetic people in developing countries use a medicinal herb called Gymnema slyvestre to help control sugar levels. He decided to study the microbiological use of Gymnema slyvestre -- a tropical vine plant found in India, China and Australia -- to see if it could treat a common human fungal pathogen called Candida albicans.

The investigation was successful on two levels: Vediyappan's research team found the medicinal compound is both nontoxic and blocks the virulence properties of the fungus so that it is more treatable. The results are important for human health, biomedical applications and potential drug development.

"We have shown that this compound is safe to use because it doesn't hurt our body cells, yet it blocks the virulence of this fungus under in vitro conditions," Vediyappan said. "Taking the medicine could potentially help patients control the invasive growth of the fungus and also help bring their sugar levels down."

Candida albicans is one of the major fungal pathogens in humans because it lives in oral and intestinal areas as a normal flora, Vediyappan said. But the fungus can overgrow and can cause oral, intestinal and genital infections. The mortality rates for those with candidemia and invasive candidiasis has been reported to be quite high, and it is a concern among cancer patients -- especially patients with neck or oral cancer -- HIV patients, organ transplant patients and other people with compromised immune systems.

The fungus can grow in two forms: a treatable yeast and a difficult-to-treat hyphal form. Once the fungus transforms from a yeast to a hyphal growth it becomes difficult to treat because the hyphal growth has long filament-like structures that can spread into various organs. Vediyappan's study aimed to block the hyphal growth form.

"Once it gets into the tissue, it spreads like roots and is difficult to contain by our immune system," Vediyappan said.

If the fungus remains in yeast form, it is easy to manage and does not invade tissues. Vediyappan's research team purified gymnemic acid compounds that prevented the transition stage from occurring and stopped the fungus spread. The gymnemic acids come from the leaves of Gymnema sylvestre, a traditional medicinal plant.

The research appears in the peer-reviewed journal PLOS ONE in an article titled "Gymnemic acids inhibit hyphal growth and virulence in Candida albicans."

Gymnema extract is commonly used to treat diabetes and other ailments because it is a cost-effective treatment, Vediyappan said. Often, people drink the extract to control their sugar levels or to lose weight.

Although Vediyappan's research team is not the first to discover gymnemic acid compounds, the team is the first to discover that the compounds block the fungal transition. The researchers found that the compounds work quickly, too, which was an important characteristic. The treatable fungal yeast can transition to a hyphal growth within 30 minutes of an infection. When the hyphal transition has occurred, it will grow into branched filaments.

The gymnemic acid compounds are nontoxic, which is especially important for cancer patients and other immunocompromised patients. The gymnemic acids can stop the unwanted invasive infection while preserving important healthy cells.

The Candida albicans fungus also makes a biofilm, which is a fungal cell collection that can be difficult to treat. The researchers found that the gymnemic acid compounds converted the biofilm back to treatable yeast cells.

"This compound prevents the biofilm formation because hyphae are the major builders of biofilms and biofilms are resistant to antifungals," Vediyappan said. "Yeast cells by themselves cannot make biofilms and are sensitive to antifungal treatments."

Another interesting aspect: The gymnemic acid compounds also stopped the growth of Aspergillus, another fungal pathogen that can affect heart transplant patients and leukemia patients.

Vediyappan plans future studies to research mode of action, potential drug development, diabetes applications and other ways to improve treatment for Candida albicans and other fungal pathogens.

Kansas State University. "Treat the fungus among us with nontoxic medicinal compound." ScienceDaily. ScienceDaily, 12 September 2013. <www.sciencedaily.com/releases/2013/09/130912131803.htm>.

Kansas State University. (2013, September 12). Treat the fungus among us with nontoxic medicinal compound. ScienceDaily. Retrieved March 3, 2015 from www.sciencedaily.com/releases/2013/09/130912131803.htm

Kansas State University. "Treat the fungus among us with nontoxic medicinal compound." ScienceDaily. www.sciencedaily.com/releases/2013/09/130912131803.htm (accessed March 3, 2015).

Mar. 3, 2015 — Rather than just waiting patiently for any pollinator that comes their way to start the next generation of seeds, some plants appear to recognize the best suitors and 'turn on' to increase the chance ... full story

Mar. 3, 2015 — Two of the four known groups of human AIDS viruses (HIV-1 groups O and P) have originated in western lowland gorillas, according to new research. The scientists conducted a comprehensive survey of ... full story

Mar. 3, 2015 — Methane emissions are strongly reduced in lakes with anoxic bottom waters. But – contrary to what has previously been assumed – methane removal is not always due to archaea or anaerobic bacteria. ... full story

Mar. 2, 2015 — For the first time, researchers have produced a 3-D image revealing part of the inner structure of an intact, infectious virus, using a unique X-ray laser. The virus, called Mimivirus, is in a ... full story

Mar. 2, 2015 — In the first study of its kind since the 1920s, rats in New York City were found to carry a flea species capable of transmitting plague pathogens. Among them: 500-plus Oriental rat fleas, notorious ... full story

Mar. 2, 2015 — What do a human colon, septic tank, copper nanoparticles and zebrafish have in common? They were the key components used by researchers to study the impact copper nanoparticles, which are found in ... full story

Mar. 2, 2015 — You might resemble or act more like your mother, but a novel research study reveals that mammals are genetically more like their dads. Specifically, the research shows that although we inherit equal ... full story

Mar. 2, 2015 — Researchers have examined the association of nut and peanut consumption with mortality among low-income and racially diverse populations and found that intake of peanuts was associated with fewer ... full story

Mar. 2, 2015 — Hungry, plant-eating insects may limit the ability of forests to take up elevated levels of carbon dioxide in the atmosphere, reducing their capacity to slow human-driven climate change, a new study ... full story

Zookeepers Copy Animal Poses In Hilarious Viral Photos

Buzz60 (Mar. 2, 2015) — Zookeepers at the Symbio Wildlife Park in Helensburgh, Australia decided to take some of their favorite animal photos and recreate them by posing just like the animals. Jen Markham (@jenmarkham) has the story.
Video provided by Buzz60

Aug. 20, 2014 — One of the world's largest gene libraries for the Candida glabrata yeast, which is harmful to humans, has been developed by researchers. Molecular analysis of the Candida glabrata fungus ... full story

July 24, 2012 — Researchers have now shown how a common fungus can adjust its physiology to become harmful in a host with compromised immune status. The study is the first to demonstrate that the hospitality of the ... full story

May 31, 2012 — Researchers have made breakthrough use of 3-D magnetic resonance technology to map the structure of Candida, a common fungus that is potentially deadly for individuals with impaired immune function. ... full story

Sep. 6, 2011 — Fungi that cause severe infections in those with compromised immune systems are resisting the action of the latest group of antifungal drugs. Uncovering their strategies for doing this will lead to ... full story

ScienceDaily features breaking news and videos about the latest discoveries in health, technology, the environment, and more -- from major news services and leading universities, scientific journals, and research organizations.